Intrinsic Value of S&P & Nasdaq Contact Us

Olink Holding AB (publ) OLK NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • SE • USD

SharesGrow Score
32/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.50
-17.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Olink Holding AB (publ) (OLK) , forward earnings yield 0.19%. PEG 2.70.

Criteria proven by this page:

  • VALUE (20/100, Fail) — analyst consensus target implies downside from the current price ($21.50, 17.6%); PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 2.70).
  • Forward P/E 521.6
  • PEG Ratio 2.70 — above 2.0 suggests expensive relative to earnings growth.
  • Analyst consensus target $21.50 (-17.6% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 32/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
32/100
SG Score
View full scorecard →
VALUE
20/100
Price-to-Earnings & upside
Proven by this page
FUTURE
16/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
55/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — OLK

Valuation Multiples
P/E (TTM)0.0
Forward P/E521.6
PEG Ratio2.70
Forward PEG2.70
P/B Ratio0.00
P/S Ratio19.03
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.26
Forward EPS (Est.)$0.05
Book Value / Share$0.00
Revenue / Share$1.37
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield0.19%
Dividend Yield0.00%
Analyst Target$21.50 (-17.6%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.07 $41.69M $-17.88M -42.9%
2020 $-0.03 $54.07M $-6.78M -12.5%
2021 $-0.39 $94.97M $-38.34M -40.4%
2022 $-0.11 $139.85M $-12.85M -9.2%
2023 $-0.26 $169.91M $-31.66M -18.6%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message